AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Find out which savings strategy is most effective for your financial goals. Implement these strategies for better savings.
26,213 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Emails released in SEC filings reveal a heated confrontation between UWM and Two Harbors as the CCM deal vote approac...
Retirees are shifting toward stable, long-running income. This report explains why high-yielding dividend kings retir...
Pi2Day brings three new services to Pi Network, expanding into AI, identity, and third-party apps. Markets respond wi...
Meta’s foray into cloud services, dubbed Meta Compute, sparks a selloff in AI infrastructure peers Nebius, CoreWeave,...
KBW argues United Wholesale Mortgage could emerge stronger after failing to win Two Harbors, with faster debt reducti...
Oil markets swung dramatically in the first half, with prices surging and then cooling. This guide explains what that...
SpaceX dazzled investors at IPO, but the price soon drifted below debut. This article shows how a $10,000 investment ...
The Metals Company stock faced a sharp pullback in early 2026 after a dramatic rally in the previous year. This artic...
A rally in AeroVironment shares has investors wondering what sparked the move. This guide breaks down the factors beh...
SoFi Technologies posted record fourth-quarter results and added a million members, yet the stock sits around $18. Th...
A 46-year-old investor with $21 million contemplates retirement as a newborn arrives. The decision hinges on family p...